AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 25564179
Drug: Peritonsillar infiltration
RxNorm normalized name: Autologous tumor infiltrating lymphocytes
DrugBank: Lifileucel (DB17107)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peritonsillar infiltration of ketamine 1.0 mg/kg added to peritonsillar tramadol 2 mg/kg
Trial: 25564179
Drug: Peritonsillar saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peritonsillar saline and peritonsillar infiltration of tramadol 2 mg/kg
Trial: 21181914
Drug: Inactivated hepatitis
RxNorm normalized name: Inactivated hepatitis A vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactivated hepatitis A vaccine (0-6 month schedule)
Trial: 19793040
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application (clindamycin, dexamethasone)
Trial: 19793040
Drug: Systemic application
RxNorm normalized name: Vaginal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic application (cefprozil, amoxicillin+clavulanate)
Trial: 19793040
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no medications except analgesic)
Trial: 17382220
Drug: Alvimopan 12
RxNorm normalized name: alvimopan 12 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alvimopan 12 mg administered 30 minutes or more preoperatively and twice daily postoperatively until hospital discharge (7 or fewer postoperative days)
Trial: 15041504
Drug: Tramadol plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol plus acetaminophen (APAP) 37.5 mg tramadol plus 325 mg APAP (n = 98)
Trial: 15041504
Drug: Tramadol plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol plus acetaminophen (APAP)
Trial: 15041504
Drug: Codeine 30
RxNorm normalized name: codeine 30 MG
DrugBank: Codeine (DB00318)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Codeine 30 mg plus APAP 300 mg (n = 109)
Trial: 15041504
Drug: Codeine plus
RxNorm normalized name: Codeine
DrugBank: Codeine (DB00318)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Codeine plus acetaminophen (APAP)
Trial: 7905919
Drug: lorazepam (.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lorazepam (.05 mg/kg)
Trial: 7905919
Drug: diazepam (.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: diazepam (.25 mg/kg)
Trial: 7905919
Drug: midazolam (.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: midazolam (.1 mg/kg)
Trial: 2567114
Drug: Dilevalol (200,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dilevalol (200, 400, 800, 1,600 mg)
Trial: 2567114
Drug: Metoprolol (100,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (100, 200, 300, 400 mg)
Trial: 2567114
Drug: Dilevalol (100,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dilevalol (100, 200, 400, 800 mg)
Trial: 5312322
Drug: Isoniazid (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoniazid (5 mg/kg body-weight daily)
Trial: 28467383
Drug: Total urinary
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total urinary polyphenol excretion (TPE) measured by the Folin‐Ciocalteu method
Trial: 16563521
Drug: Olanzapine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine (5 to 20 mg/d)
Trial: 16563521
Drug: Olanzapine-fluoxetine combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine-fluoxetine combination (6 and 25, 6 and 50, or 12 and 50 mg/d)
Trial: 12878921
Drug: Ondansetron (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron (4 microg/kg twice daily for 8 weeks)
Trial: 10719404
Drug: Pecan treatment
RxNorm normalized name: Pecan
DrugBank: Pecan (DB10555)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pecan treatment group (68 g pecans per day for 8 weeks)
Trial: 10719404
Drug: Pecan treatment
RxNorm normalized name: Pecan
DrugBank: Pecan (DB10555)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pecan treatment group
Trial: 1358119
Drug: (-)-3PPP (preclamol)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: (-)-3PPP (preclamol) administered intramuscularly at doses of 30-40 mg
Trial: 24571169
Drug: Probiotics, taken
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotics, taken twice a day for 2 weeks before surgery
Trial: 24571169
Drug: Placebo, taken
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, taken twice a day for 2 weeks before surgery
Trial: 22753904
Drug: Dose-escalated cetuximab
RxNorm normalized name: Cetuximab
DrugBank: Cetuximab (DB00002)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Dose-escalated cetuximab (500 mg/m2 per week)
Trial: 22753904
Drug: Standard-dose cetuximab
RxNorm normalized name: Cetuximab
DrugBank: Cetuximab (DB00002)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Standard-dose cetuximab (400 mg/m2 initial dose, then 250 mg/m2 per week)
Trial: 22753904
Drug: Dose-escalated cetuximab
RxNorm normalized name: Cetuximab
DrugBank: Cetuximab (DB00002)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Dose-escalated cetuximab (500 mg/m2 per week) in KRAS wild-type tumors
Trial: 22753904
Drug: Standard-dose cetuximab
RxNorm normalized name: Cetuximab
DrugBank: Cetuximab (DB00002)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Standard-dose cetuximab (400 mg/m2 initial dose, then 250 mg/m2 per week) in KRAS wild-type tumors
Trial: 20444847
Drug: First-line chemotherapy
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: First-line chemotherapy with carcinoembryonic antigen (CEA) and carbohydrate antigen (CA) 15-3 monitoring
Trial: 12114886
Drug: Duloxetine (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine (all doses) in severe cases
Trial: 11035129
Drug: Tiaprofenic acid
RxNorm normalized name: tiaprofenic acid
DrugBank: Tiaprofenic acid (DB01600)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiaprofenic acid (300 mg b.d.)
Trial: 11035129
Drug: Indomethacin (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (25 mg t.d.s.)
Trial: 8633584
Drug: Regimen 1
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regimen 1 (B 150 mg q.i.d., OT 500 mg q.i.d., M 400 mg t.i.d. for 10 days and R 300 mg b.i.d. for 4 wk)
Trial: 8633584
Drug: Ranitidine (during
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine (during therapy)
Trial: 26176643
Drug: Aliskiren (150-300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aliskiren (150-300 mg)/Amlodipine (5 mg) (ALI/AML group, n=53)
Trial: 26176643
Drug: High-dose Amlodipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose Amlodipine (10 mg) (h-dAML group, n=52)
Trial: 17470315
Drug: ondansetron (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ondansetron (0.25 mg, 1 mg, or 4 mg b.i.d.)
Trial: 30094885
Drug: Vaginal washing
RxNorm normalized name: Zencia Wash
DrugBank: Octasulfur (DB09353)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal washing before intravaginal dinoprostone insertion (10 mg dinoprostone via Propess system)
Trial: 26990824
Drug: Early integrated
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early integrated ART initiation during TB treatment
Trial: 26990824
Drug: Late integrated
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Late integrated ART initiation during TB treatment
Trial: 26990824
Drug: Delayed ART
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Delayed ART initiation after TB treatment completion
Trial: 20048658
Drug: Intraoperative thoracic
RxNorm normalized name: Thoracol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraoperative thoracic epidural bupivacaine perfusion (0.5% at 3 mL/hr) with preoperative intrathecal morphine (0.5 mg) and fentanyl (15 microg)
Trial: 12472591
Drug: Subcutaneous lenograstim
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous lenograstim during the first 12 weeks of standard immunosuppressive therapy
Trial: 12472591
Drug: Standard immunosuppressive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard immunosuppressive therapy (control group)
Trial: 8749707
Drug: Intravenous immune
RxNorm normalized name: Intravenous immune globulin (human)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immune globulins (IVIg)
Trial: 8749707
Drug: Plasma exchange
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plasma exchange (PE) and Intravenous immune globulins (IVIg)
Trial: 8749707
Drug: Single therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single therapy (either PE or IVIg)
Trial: 8749707
Drug: Second cycle
RxNorm normalized name: 60 Second
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Second cycle of therapy (either PE or IVIg)
Trial: 324571
Drug: Single preoperative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single preoperative dose of cephazolin
Trial: 324571
Drug: Single preoperative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single preoperative dose of cephazolin plus a five-day course postoperatively
Trial: 29205165
Drug: Targeted prophylactic
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Targeted prophylactic antibiotic regime (Group 2, n=144)
Trial: 29205165
Drug: Targeted prophylactic
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Targeted prophylactic antibiotic regime (Group 2)
Trial: 25726497
Drug: Active DBS
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active DBS treatment
Trial: 25726497
Drug: Sham DBS
RxNorm normalized name: miconazole
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Sham DBS treatment
Trial: 19804515
Drug: Adenosine (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adenosine (12 mg)
Trial: 11783325
Drug: Integrated traditional
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Integrated traditional Chinese and Western medicine (TCM-WM) treatment including prednisone, Cytoxan (CTX), and Chinese medicinal herbs according to Syndrome-type.
Trial: 11783325
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group treated with Western medicine (WM) alone.
Trial: 11783325
Drug: Integrated traditional
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Integrated traditional Chinese and Western medicine (TCM-WM) treatment.
Trial: 3899240
Drug: Low-molecular-weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-molecular-weight heparin (LMW heparin) 1850 APTT units (7500 antifactor Xa units)
Trial: 3899240
Drug: Unfractionated (UF)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unfractionated (UF) calcium heparin 10000 APTT units
Trial: 3899240
Drug: Single injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single injection of LMW heparin every day
Trial: 30382820
Drug: Birth weight
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Birth weight of > 3600 g
Trial: 24068750
Drug: Combined cognitive-behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined cognitive-behavioral psychotherapy (14 one-hour weekly sessions)
Trial: 24068750
Drug: Conventional cognitive-behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional cognitive-behavioral psychotherapy (14 one-hour weekly sessions)
Trial: 22673017
Drug: Tetrahydrobiopterin (BH(4))
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tetrahydrobiopterin (BH(4)) 10 mg·kg(‐1) body weight
Trial: 19001248
Drug: Carisbamate 300
RxNorm normalized name: Chlorphenesin Carbamate
DrugBank: Chlorphenesin carbamate (DB14656)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carisbamate 300 mg/d
Trial: 19001248
Drug: Carisbamate 800
RxNorm normalized name: Chlorphenesin Carbamate
DrugBank: Chlorphenesin carbamate (DB14656)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carisbamate 800 mg/d
Trial: 19001248
Drug: Carisbamate 1,600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carisbamate 1,600 mg/d
Trial: 15746990
Drug: Weight loss
RxNorm normalized name: HERBAL WEIGHT LOSS AID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weight loss with normal calcium intake (1 g/day)
Trial: 15746990
Drug: Weight loss
RxNorm normalized name: HERBAL WEIGHT LOSS AID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weight loss with high calcium intake (1.7 g/day)
Trial: 15746990
Drug: Weight maintenance
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weight maintenance with normal calcium intake (1 g/day)
Trial: 2141110
Drug: Sequential ultrafiltration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential ultrafiltration (UF; 1 litre/h)
Trial: 2141110
Drug: Sequential ultrafiltration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential ultrafiltration (UF) during BC-UF
Trial: 2141110
Drug: Sequential ultrafiltration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential ultrafiltration (UF)
Trial: 6109648
Drug: Mefenamic acid
RxNorm normalized name: Mefenamic Acid
DrugBank: Mefenamic acid (DB00784)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mefenamic acid (500 mg every eight hours for a maximum of three days during menstruation for three consecutive cycles)
Trial: 24534317
Drug: Remifentanyl and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanyl and propofol injection (Group A)
Trial: 24534317
Drug: Oxycodone hydrochloride
RxNorm normalized name: Oxycodone Hydrochloride
DrugBank: Oxycodone (DB00497)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oxycodone hydrochloride (Group B)
Trial: 20376076
Drug: nebivolol (5-10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nebivolol (5-10 mg/day) for 8 weeks
Trial: 12699210
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of glucocorticoid and beta‐agonist (n = 52)
Trial: 12699210
Drug: Beta‐agonist alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta‐agonist alone (n = 11)
Trial: 9378464
Drug: Cytotoxic chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytotoxic chemotherapy (CT) for ALL
Trial: 7901258
Drug: Dapiprazole administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapiprazole administered as directed by its manufacturer after pupil dilation with proparacaine 0.5%, hydroxyamphetamine 1.0%, and tropicamide 0.25%.
Trial: 3961029
Drug: S-adenosyl-methionine (SAMe)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-adenosyl-methionine (SAMe) 400 mg single dose and seven daily administrations
Trial: 3961029
Drug: Chronic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chronic treatment with monoamine oxidase inhibitors (MAOIs)
Trial: 20705561
Drug: Chemotherapy plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy plus trastuzumab (H0648g)
Trial: 20705561
Drug: Chemotherapy (Control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (Control in H0648g)
Trial: 20705561
Drug: Trastuzumab monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trastuzumab monotherapy (H0649g)
Trial: 20705561
Drug: Trastuzumab monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trastuzumab monotherapy (H0650g)
Trial: 15928305
Drug: Ursodeoxycholic acid
RxNorm normalized name: Ursodeoxycholic acid
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodeoxycholic acid (UDCA) treatment (8-10 mg/kg of body weight; 661 participants)
Trial: 15928305
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment (624 participants)
Trial: 12595838
Drug: Metoprolol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (100 mg per day, increased to 150 mg per day after 411 patients enrolled)
Trial: 3048075
Drug: 50 g
RxNorm normalized name: glucose 50 g/296 mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 g glucose and 40 g fat
Trial: 3048075
Drug: 50 g
RxNorm normalized name: glucose 50 g/296 mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 g fructose and 40 g fat
Trial: 3048075
Drug: 100 g
RxNorm normalized name: Berri-Freez 4.5 GM per 100 GM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 g sucrose and 40 g fat
Trial: 3048075
Drug: 40 g
RxNorm normalized name: PEG-40 GLYCERYL STEARATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 g fat alone
Trial: 31609930
Drug: Bictegravir, Emtricitabine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bictegravir, Emtricitabine, and Tenofovir Alafenamide (B/F/TAF) 50/200/25 mg
Trial: 27000071
Drug: TENS therapy
RxNorm normalized name: Walgreens Electronic TENS Therapy Pain Relief Pad
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TENS therapy for 10 weeks
Trial: 27000071
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no TENS therapy)
Trial: 16028147
Drug: Standard 4-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard 4-dose course of dihydroartemisinin-piperaquine (DP4)
Trial: 16028147
Drug: Once-daily regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily regimen of dihydroartemisinin-piperaquine (DP3)
Trial: 11824390
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of radiotherapy with cisplatin based chemotherapy
Trial: 11824390
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of radiotherapy with hyperthermia
Trial: 11824390
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of radiotherapy, cisplatin, and hyperthermia
Trial: 8308183
Drug: Oral cat
RxNorm normalized name: cat hair extract
DrugBank: Felis catus hair (DB10499)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral cat immunotherapy (2.5 x 10(6) allergy units or 436 U Fel d I administered over 3 months)
Trial: 8308183
Drug: Oral cat
RxNorm normalized name: cat hair extract
DrugBank: Felis catus hair (DB10499)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral cat immunotherapy
Trial: 1092131
Drug: Oral ferrous
RxNorm normalized name: ferrous fumarate Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ferrous iron 2000 mg after each blood donation
Trial: 1092131
Drug: Oral ferrous
RxNorm normalized name: ferrous fumarate Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ferrous iron 1000 mg after each blood donation
Trial: 1092131
Drug: Oral ferrous
RxNorm normalized name: ferrous fumarate Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ferrous iron 2000 mg after four months between donations
Trial: 31612475
Drug: Minimal oral
RxNorm normalized name: Centipeda minima whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minimal oral intake during nutrition support
Trial: 31612475
Drug: Additional beta
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Additional beta lactam antibiotics
Trial: 26690313
Drug: BND 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BND 600 mg
Trial: 26690313
Drug: BND 1,200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BND 1,200 mg
Trial: 25155931
Drug: Combined OPRM1
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined OPRM1 118A>G and COMT 472G>A genotype
Trial: 20460233
Drug: HMB (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HMB (2 g/d)
Trial: 7486087
Drug: Epidural fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Epidural fentanyl 5 micrograms/mL
Trial: 7486087
Drug: Epidural fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Epidural fentanyl 10 micrograms/mL
Trial: 7851059
Drug: Normal daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal daily activity
Trial: 31655508
Drug: Pregabalin (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin (150 mg tablet given the night before and 1 hour before the operation)
Trial: 31655508
Drug: Pregabalin (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin (150 mg tablet)
Trial: 24121184
Drug: 50:40:10 mixture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50:40:10 mixture of MCT, soybean oil, and fish oil (treatment)
Trial: 17298423
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy plus add-on omalizumab
Trial: 14517707
Drug: BIA 3-202
RxNorm normalized name: Oatmeal 10 mg in 1 mL TOPICAL CREAM [BIA Eczema Relief]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BIA 3-202 50 mg
Trial: 14517707
Drug: BIA 3-202
RxNorm normalized name: Oatmeal 10 mg in 1 mL TOPICAL CREAM [BIA Eczema Relief]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BIA 3-202 100 mg
Trial: 14517707
Drug: BIA 3-202
RxNorm normalized name: Oatmeal 10 mg in 1 mL TOPICAL CREAM [BIA Eczema Relief]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BIA 3-202 200 mg
Trial: 14517707
Drug: BIA 3-202
RxNorm normalized name: Oatmeal 10 mg in 1 mL TOPICAL CREAM [BIA Eczema Relief]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BIA 3-202 400 mg
Trial: 11081780
Drug: Acute salt
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acute salt loading with a 2 h infusion of isotonic saline